SARS‐CoV‐2 Omicron variant seemed to cause milder disease compared to previous
predominated variants. We aimed to conduct a meta‐analysis to assess the pooled …

The clinical implications of COVID-19 have changed since SARS-CoV-2 first emerged in
humans. The current high levels of population immunity, due to prior infection and/or …

Background Solid organ transplant (SOT) recipients are at increased risks of morbidity and
mortality associated with COVID-19. Objectives This study aimed to evaluate the …

Treatment outcomes associated with the use of novel COVID-19 therapeutics in solid organ
transplant recipients (SOTR) are not well described in the literature. The objective of this …

Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over
the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the 29
causative pathogen of Coronavirus disease 2019 (COVID-19), has resulted in over 650 30 …

At the start of the pandemic, liver transplant recipients (LTR) were at high risk of developing
severe COVID-19. Here, the outcomes of breakthrough infections in fully vaccinated LTR (n …

• COVID-19 vaccine responses in SOT are poor 16• 3 or greater vaccine doses result in
superior antibody responses compared to 2 doses, 17 but some people do not respond …

A total of 1801> 3×-vaccinated SOTRs from our national observational cohort were surveyed
about incident COVID-19 during the Omicron wave, of whom 1467 (81%) responded. A …

Abstract Background Organ transplant recipients (OTRs) are less protected from vaccination
than immunocompetent hosts. Additional vaccine doses have shown increased …